Pontifax Management 4 G.P. (2015) Ltd. has filed 7 insider transactions across 2 companies since September 2025.
Most recent transaction: a sale of 2284612 shares of Keros Therapeutics, Inc. ($KROS) on October 15, 2025.
Activity breakdown: 1 open-market purchase and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 15, 2025 | Keros Therapeutics, Inc. | $KROS | Pontifax Management 4 G.P. (2015) Ltd. | TenPercentOwner | S | Common Stock, $0.0001 par value per share | 2284612 | $17.75 | 10,500.0000 | 41,202,371 | 99.54% | 5.54% |
| Oct. 15, 2025 | Keros Therapeutics, Inc. | $KROS | Pontifax Management 4 G.P. (2015) Ltd. | TenPercentOwner | S | Common Stock, $0.0001 par value per share | 1121045 | $17.75 | 10,500.0000 | 41,202,371 | 99.07% | 2.72% |
| Oct. 15, 2025 | Keros Therapeutics, Inc. | $KROS | Pontifax Management 4 G.P. (2015) Ltd. | TenPercentOwner | S | Common Stock, $0.0001 par value per share | 1226412 | $17.75 | 10,500.0000 | 41,202,371 | 99.15% | 2.98% |
| Oct. 15, 2025 | Keros Therapeutics, Inc. | $KROS | Pontifax Management 4 G.P. (2015) Ltd. | TenPercentOwner | S | Common Stock, $0.0001 par value per share | 155262 | $17.75 | 10,500.0000 | 41,202,371 | 93.67% | 0.38% |
| Sept. 12, 2025 | LB PHARMACEUTICALS INC | $LBRX | Pontifax Management 4 G.P. (2015) Ltd. | Not found | P | Common Stock | 1000000 | $15.00 | 1,411,681.0000 | 0 | 242.91% | 0.00% |
| Sept. 12, 2025 | LB PHARMACEUTICALS INC | $LBRX | Pontifax Management 4 G.P. (2015) Ltd. | Not found | C | Series C Preferred Stock | 10000000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 12, 2025 | LB PHARMACEUTICALS INC | $LBRX | Pontifax Management 4 G.P. (2015) Ltd. | Not found | C | Common Stock | 411681 | $0.00 | 411,681.0000 | 0 | 9999.99% | 0.00% |